Trial · NCT02100722
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | MACCE | 1 year | Death, MI, stroke and any repeat revascularization (MACCE) will be evaluated at 1 year, where subjects contribute data from time of randomization until the occurrence of MACCE or one year follow-up, whichever occurs first. Subjects who die or are lost to follow up before 1 year will be censored at their last recorded activity. |
| Secondary | Key Secondary Outcome: Composite of Death From Any Cause, Myocardial Infarction, or Stroke | 3 years | Death, MI, or stroke at 3-year follow-up |
| Secondary | Number of Participants Experiencing Death, MI, or Stroke | 1 year | Subjects who died or are lost to follow up before this time were censored at their last recorded activity. |
| Secondary | Death | 1 year | Death evaluated excluding patients lost to follow-up from each arm |
| Secondary | Number of Participants Experiencing Myocardial Infarction | 1 year | MI evaluated excluding patients lost to follow-up from each arm |
| Secondary | Number of Participants Experiencing Stroke | 1 year | Stroke evaluated excluding patients lost to follow-up from each arm. |
| Secondary | Number of Participants Requiring Repeat Revascularization | 1 year | Any repeat revascularization evaluated excluding patients lost to follow-up from each arm |
| Secondary | Number of Participants Experiencing BARC Type 3-5 Bleeding | 1 year | Bleeding Academic Research Consortium (BARC) type 3-5 indicates severe bleeding. |
| Secondary | Number of Participants Experiencing Acute Kidney Injury | 1 year | |
| Secondary | Number of Participants Experiencing Atrial Fibrillation or Clinically Significant Arrhythmia | 1 year | |
| Secondary | Number of Participants Experiencing Definite Stent Thrombosis | 1 year | |
| Secondary | Number of Participants Experiencing Definite Symptomatic Graft Occlusion | 1 year | |
| Secondary | Number of Participants Requiring Rehospitalization Within 30 Days | 30 days | |
| Secondary | MACCE | 5 years | Death, MI, stroke and any repeat revascularization (MACCE) rate at 5 years |
| Secondary | Death, MI, or Stroke at 5 Years | 5 years | Death, MI, or stroke at 5 years |
| Secondary | Individual Components of Primary Outcome | At year 3 | Individual components of primary outcome: number of participants experiencing death, myocardial infarction, and stroke |
| Secondary | Individual Components of Primary Outcome | At year 5 | Individual components of primary outcome: number of participants experiencing death, myocardial infarction, and stroke |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02100722/registered